Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Salivary miR-93 and miR-200a as post-radiotherapy biomarkers in head and neck squamous cell carcinoma.

Greither T, Vorwerk F, Kappler M, Bache M, Taubert H, Kuhnt T, Hey J, Eckert AW.

Oncol Rep. 2017 Aug;38(2):1268-1275. doi: 10.3892/or.2017.5764. Epub 2017 Jun 28.

PMID:
28677748
2.

A novel saliva-based microRNA biomarker panel to detect head and neck cancers.

Salazar C, Nagadia R, Pandit P, Cooper-White J, Banerjee N, Dimitrova N, Coman WB, Punyadeera C.

Cell Oncol (Dordr). 2014 Oct;37(5):331-8. doi: 10.1007/s13402-014-0188-2. Epub 2014 Aug 26.

PMID:
25156495
3.

Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.

Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF, Yang MY.

Tumour Biol. 2012 Dec;33(6):1933-42. doi: 10.1007/s13277-012-0454-8. Epub 2012 Jul 19.

PMID:
22811001
4.

Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.

Hou B, Ishinaga H, Midorikawa K, Shah SA, Nakamura S, Hiraku Y, Oikawa S, Murata M, Takeuchi K.

Cancer Biol Ther. 2015;16(7):1042-6. doi: 10.1080/15384047.2015.1045692. Epub 2015 May 7.

5.

Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers.

Hudcova K, Raudenska M, Gumulec J, Binkova H, Horakova Z, Kostrica R, Babula P, Adam V, Masarik M.

Tumour Biol. 2016 Sep;37(9):12627-12633. Epub 2016 Jul 20.

PMID:
27440205
6.

Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.

Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H.

Oncol Rep. 2010 Jun;23(6):1625-33.

PMID:
20428818
7.

Salivary microRNAs as promising biomarkers for detection of esophageal cancer.

Xie Z, Chen G, Zhang X, Li D, Huang J, Yang C, Zhang P, Qin Y, Duan Y, Gong B, Li Z.

PLoS One. 2013;8(4):e57502. doi: 10.1371/journal.pone.0057502. Epub 2013 Apr 1.

8.

miR-205 in situ expression and localization in head and neck tumors - a tissue array study.

Nurul-Syakima AM, Learn-Han L, Yoke-Kqueen C.

Asian Pac J Cancer Prev. 2014;15(21):9071-5.

9.

MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.

Ahmad P, Sana J, Slavik M, Slampa P, Smilek P, Slaby O.

Dis Markers. 2017;2017:8245345. doi: 10.1155/2017/8245345. Epub 2017 Feb 23. Review.

10.

Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck.

Odar K, Boštjančič E, Gale N, Glavač D, Zidar N.

Histopathology. 2012 Aug;61(2):257-65. doi: 10.1111/j.1365-2559.2012.04242.x. Epub 2012 Jun 13.

PMID:
22690848
11.

Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.

de Carvalho AC, Scapulatempo-Neto C, Maia DC, Evangelista AF, Morini MA, Carvalho AL, Vettore AL.

BMC Med. 2015 May 9;13:108. doi: 10.1186/s12916-015-0350-3. Erratum in: BMC Med. 2015;13:155.

12.

MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.

Arantes LM, Laus AC, Melendez ME, de Carvalho AC, Sorroche BP, De Marchi PR, Evangelista AF, Scapulatempo-Neto C, de Souza Viana L, Carvalho AL.

Oncotarget. 2017 Feb 7;8(6):9911-9921. doi: 10.18632/oncotarget.14253.

13.

Association of microRNA polymorphisms with the risk of head and neck squamous cell carcinoma in a Chinese population: a case-control study.

Miao L, Wang L, Zhu L, Du J, Zhu X, Niu Y, Wang R, Hu Z, Chen N, Shen H, Ma H.

Chin J Cancer. 2016 Aug 11;35(1):77. doi: 10.1186/s40880-016-0136-9.

14.

Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.

Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ, Schlecht NF.

Am J Pathol. 2009 Mar;174(3):736-45. doi: 10.2353/ajpath.2009.080731. Epub 2009 Jan 29.

15.

Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.

Li G, Ren S, Su Z, Liu C, Deng T, Huang D, Tian Y, Qiu Y, Liu Y.

Tumour Biol. 2015 May;36(5):3949-56. doi: 10.1007/s13277-015-3038-6. Epub 2015 Jan 13.

16.

Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.

Yan Y, Wang X, Venø MT, Bakholdt V, Sørensen JA, Krogdahl A, Sun Z, Gao S, Kjems J.

Oncotarget. 2017 Jan 31;8(5):8206-8214. doi: 10.18632/oncotarget.14143.

17.

MicroRNA profile in site-specific head and neck squamous cell cancer.

Kalfert D, Pesta M, Kulda V, Topolcan O, Ryska A, Celakovsky P, Laco J, Ludvikova M.

Anticancer Res. 2015 Apr;35(4):2455-63.

PMID:
25862914
18.

MicroRNA alterations in head and neck squamous cell carcinoma.

Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, Shan S, Westra W, Sidransky D, Califano JA.

Int J Cancer. 2008 Dec 15;123(12):2791-7. doi: 10.1002/ijc.23831.

19.

Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.

Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CM.

Oncogene. 2014 Feb 6;33(6):702-12. doi: 10.1038/onc.2013.13. Epub 2013 Feb 18.

20.

Analysis of Saliva Gene Expression during Head and Neck Cancer Radiotherapy: A Pilot Study.

Lacombe J, Brooks C, Hu C, Menashi E, Korn R, Yang F, Zenhausern F.

Radiat Res. 2017 Jul;188(1):75-81. doi: 10.1667/RR14707.1. Epub 2017 May 15.

Supplemental Content

Support Center